Neuronetics Reports Strong Fourth Quarter and 2023 Results, Launches Patient-Oriented Program
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a leading-edge medtech corporation, recently showcased robust financial results for the fourth quarter and full year of 2023, hoping to continue the upward …
Neuronetics Reports Strong Fourth Quarter and 2023 Results, Launches Patient-Oriented Program Read More